EDITORIAL
Published on 16 Jan 2024
Editorial: SARS-CoV-2 in neurodegenerative diseases
doi 10.3389/fnins.2024.1360234
- 1,484 views
- 1 citation
- Frontiers in Neuroscience
- Neurodegeneration
- Research Topics
- SARS-CoV-2 in Neurodegenerative Diseases
SARS-CoV-2 in Neurodegenerative Diseases
11k
Total downloads
49k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 08 Jan 2024
The determinants of COVID-induced brain dysfunctions after SARS-CoV-2 infection in hospitalized patients
doi 10.3389/fnins.2023.1249282
- 2,227 views
- 3 citations
REVIEW
Published on 30 Aug 2023
COVID-19: a modern trigger for Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy
doi 10.3389/fnins.2023.1198327
- 6,752 views
- 4 citations
ORIGINAL RESEARCH
Published on 28 Jun 2023
The link between SARS-CoV-2 related microglial reactivity and astrocyte pathology in the inferior olivary nucleus
doi 10.3389/fnins.2023.1198219
- 2,401 views
- 7 citations
ORIGINAL RESEARCH
Published on 19 Jun 2023
Long-lasting neutralizing antibodies and T cell response after the third dose of mRNA anti-SARS-CoV-2 vaccine in multiple sclerosis
doi 10.3389/fimmu.2023.1205879
- 2,081 views
- 6 citations
MINI REVIEW
Published on 03 Mar 2023
Adamantanes for the treatment of neurodegenerative diseases in the presence of SARS-CoV-2
doi 10.3389/fnins.2023.1128157
- 2,962 views
- 8 citations
ORIGINAL RESEARCH
Published on 24 Feb 2023
SARS-CoV-2-specific antibody responses following BNT162b2 vaccination in individuals with multiple sclerosis receiving different disease-modifying treatments
doi 10.3389/fneur.2023.1092999
- 1,273 views
- 3 citations
SYSTEMATIC REVIEW
Published on 09 Feb 2023
Late neurological consequences of SARS-CoV-2 infection: New challenges for the neurologist
doi 10.3389/fnins.2023.1004957
- 3,717 views
- 13 citations
ORIGINAL RESEARCH
Published on 20 Oct 2022
Brain cortical alterations in COVID-19 patients with neurological symptoms
doi 10.3389/fnins.2022.992165
- 4,696 views
- 28 citations
ORIGINAL RESEARCH
Published on 19 Oct 2022
Risk and prognostic factors for SARS-CoV-2 infection in Spanish population with multiple sclerosis during the first five waves
doi 10.3389/fneur.2022.1001429
- 1,635 views
- 2 citations
OPINION
Published on 27 Sep 2022
SARS-CoV-2, long COVID, prion disease and neurodegeneration
doi 10.3389/fnins.2022.1002770
- 76,061 views
- 13 citations
Published in
Frontiers in Neuroscience
Neurodegeneration
Translational Neuroscience
Participating Journals
Frontiers in Immunology
- 5.9 impact factor
- 10.8 citescore
Frontiers in Neurology
- 2.8 impact factor
- 5.2 citescore